ARRY
Price
$5.04
Change
+$0.47 (+10.31%)
Updated
Apr 25, 03:44 PM (EDT)
Capitalization
2.22B
11 days until earnings call
TBPH
Price
$9.60
Change
+$0.06 (+0.63%)
Updated
Apr 25, 02:47 PM (EDT)
Capitalization
477.01M
18 days until earnings call
Ad is loading...

ARRY vs TBPH

Header iconARRY vs TBPH Comparison
Open Charts ARRY vs TBPHBanner chart's image
Array Technologies
Price$5.04
Change+$0.47 (+10.31%)
Volume$982
Capitalization2.22B
Theravance Biopharma
Price$9.60
Change+$0.06 (+0.63%)
Volume$200
Capitalization477.01M
ARRY vs TBPH Comparison Chart
Loading...
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TBPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARRY vs. TBPH commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRY is a Buy and TBPH is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (TBPH: $9.54)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TBPH’s FA Score shows that 0 FA rating(s) are green while.

  • TBPH’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARRY’s TA Score shows that 5 TA indicator(s) are bullish while TBPH’s TA Score has 4 bullish TA indicator(s).

  • ARRY’s TA Score: 5 bullish, 3 bearish.
  • TBPH’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ARRY is a better buy in the short-term than TBPH.

Price Growth

TBPH (@Biotechnology) experienced а +10.67% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.17%. For the same industry, the average monthly price growth was -4.24%, and the average quarterly price growth was -12.55%.

Reported Earning Dates

TBPH is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+7.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARRY($2.22B) has a higher market cap than TBPH($477M). TBPH YTD gains are higher at: 1.382 vs. ARRY (-24.503). ARRY has higher annual earnings (EBITDA): 276M vs. TBPH (-38.45M). ARRY has more cash in the bank: 249M vs. TBPH (88.4M). TBPH has less debt than ARRY: TBPH (49.8M) vs ARRY (730M). ARRY has higher revenues than TBPH: ARRY (1.58B) vs TBPH (64.4M).
ARRYTBPHARRY / TBPH
Capitalization2.22B477M466%
EBITDA276M-38.45M-718%
Gain YTD-24.5031.382-1,774%
P/E Ratio26.23N/A-
Revenue1.58B64.4M2,449%
Total Cash249M88.4M282%
Total Debt730M49.8M1,466%
FUNDAMENTALS RATINGS
ARRY vs TBPH: Fundamental Ratings
ARRY
TBPH
OUTLOOK RATING
1..100
1119
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
41
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9993
PRICE GROWTH RATING
1..100
9149
P/E GROWTH RATING
1..100
23100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TBPH's Valuation (41) in the Pharmaceuticals Other industry is somewhat better than the same rating for ARRY (98) in the Biotechnology industry. This means that TBPH’s stock grew somewhat faster than ARRY’s over the last 12 months.

TBPH's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ARRY (100) in the Biotechnology industry. This means that TBPH’s stock grew similarly to ARRY’s over the last 12 months.

TBPH's SMR Rating (93) in the Pharmaceuticals Other industry is in the same range as ARRY (99) in the Biotechnology industry. This means that TBPH’s stock grew similarly to ARRY’s over the last 12 months.

TBPH's Price Growth Rating (49) in the Pharmaceuticals Other industry is somewhat better than the same rating for ARRY (91) in the Biotechnology industry. This means that TBPH’s stock grew somewhat faster than ARRY’s over the last 12 months.

ARRY's P/E Growth Rating (23) in the Biotechnology industry is significantly better than the same rating for TBPH (100) in the Pharmaceuticals Other industry. This means that ARRY’s stock grew significantly faster than TBPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARRYTBPH
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
72%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 10 days ago
74%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
77%
View a ticker or compare two or three
Ad is loading...
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TBPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BCBDX11.43N/A
N/A
BlackRock Global Dividend Inv C
VBAIX45.43N/A
N/A
Vanguard Balanced Index I
TRSEX15.29N/A
N/A
Nuveen Quant Small Cap Equity Ret
STSGX10.70N/A
N/A
American Beacon Stephens Sm Cp Gr Inv
AGCVX16.99N/A
N/A
American Century Global Small Cap Inv

TBPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TBPH has been loosely correlated with ELEV. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if TBPH jumps, then ELEV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TBPH
1D Price
Change %
TBPH100%
+0.95%
ELEV - TBPH
42%
Loosely correlated
-1.80%
AXON - TBPH
34%
Loosely correlated
+2.39%
ARRY - TBPH
34%
Loosely correlated
+5.31%
KOD - TBPH
34%
Loosely correlated
+5.01%
MDGL - TBPH
30%
Poorly correlated
+3.61%
More